Advertisement

Topics

FDA fast-tracks Ironwood's heart failure candidate

05:59 EDT 14 Sep 2018 | SmartBrief

Ironwood Pharmaceuticals' IW-1973, or praliciguat, indicated to treat patients with heart failure with preserved ejection fra -More

Original Article: FDA fast-tracks Ironwood's heart failure candidate

NEXT ARTICLE

More From BioPortfolio on "FDA fast-tracks Ironwood's heart failure candidate"

Advertisement
Quick Search
Advertisement
Advertisement